168 related articles for article (PubMed ID: 28446142)
1. Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP.
Staudt M; Diederich JM; Meisel C; Meisel A; Klehmet J
BMC Neurol; 2017 Apr; 17(1):81. PubMed ID: 28446142
[TBL] [Abstract][Full Text] [Related]
2. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
3. Effective treatment with intravenous immunoglobulins reduces autoreactive T-cell response in patients with CIDP.
Klehmet J; Goehler J; Ulm L; Kohler S; Meisel C; Meisel A; Harms H
J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):686-91. PubMed ID: 25074566
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy.
Sanvito L; Makowska A; Mahdi-Rogers M; Hadden RD; Peakman M; Gregson N; Nemni R; Hughes RA
J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):333-8. PubMed ID: 19015227
[TBL] [Abstract][Full Text] [Related]
5. Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy.
Sanvito L; Makowska A; Gregson N; Nemni R; Hughes RA
Autoimmunity; 2009; 42(8):667-77. PubMed ID: 19886739
[TBL] [Abstract][Full Text] [Related]
6. Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes.
Diederich JM; Staudt M; Meisel C; Hahn K; Meinl E; Meisel A; Klehmet J
Front Neurol; 2018; 9():171. PubMed ID: 29615965
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy.
Inglis HR; Csurhes PA; McCombe PA
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):419-22. PubMed ID: 17158557
[TBL] [Abstract][Full Text] [Related]
8. Circulating lymphocyte and T memory subsets in glucocorticosteroid versus IVIG treated patients with CIDP.
Klehmet J; Staudt M; Ulm L; Unterwalder N; Meisel A; Meisel C
J Neuroimmunol; 2015 Jun; 283():17-22. PubMed ID: 26004151
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
Allen D; Giannopoulos K; Gray I; Gregson N; Makowska A; Pritchard J; Hughes RA
J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128
[TBL] [Abstract][Full Text] [Related]
10. Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Chi LJ; Wang HB; Wang WZ
J Peripher Nerv Syst; 2008 Mar; 13(1):54-63. PubMed ID: 18346231
[TBL] [Abstract][Full Text] [Related]
11. Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.
Klehmet J; Beutner S; Hoffmann S; Dornauer M; Paul F; Reilmann R; Brandt AU; Meisel A
BMC Neurol; 2019 Jun; 19(1):118. PubMed ID: 31176377
[TBL] [Abstract][Full Text] [Related]
12. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
13. Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes.
Ozdag Acarli AN; Tuzun E; Sanli E; Koral G; Akbayir E; Cakar A; Sirin NG; Soysal A; Aysal F; Durmus H; Parman Y; Yilmaz V
Clin Exp Immunol; 2024 Jan; 215(1):65-78. PubMed ID: 37638717
[TBL] [Abstract][Full Text] [Related]
14. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH
J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726
[TBL] [Abstract][Full Text] [Related]
15. Immune dysregulation in chronic inflammatory demyelinating polyneuropathy.
Li Y; Yi JS; Guptill JT; Juel VC; Hobson-Webb L; Raja SM; Karatz T; Gable KL
J Neuroimmunol; 2024 Jun; 391():578360. PubMed ID: 38723578
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated Epstein-Barr virus infection in patients with CIDP.
Lünemann JD; Tackenberg B; Stein A; Wandinger KP; Oertel WH; Wagner HJ; Münz C; Meisel H; Sommer N; Zipp F
J Neuroimmunol; 2010 Jan; 218(1-2):107-11. PubMed ID: 19939466
[TBL] [Abstract][Full Text] [Related]
17. A comparison of clinically atypical with typical chronic inflammatory demyelinating polyradiculoneuropathy.
Misra UK; Kalita J; Yadav RK
Eur Neurol; 2007; 58(2):100-5. PubMed ID: 17565223
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of chronic inflammatory demyelinating polyneuropathy].
Aranami T; Yamamura T
Nihon Rinsho; 2013 May; 71(5):850-4. PubMed ID: 23777093
[TBL] [Abstract][Full Text] [Related]
19. [A study on subpopulation of helper T cells in chronic inflammatory demyelinating polyneuropathy].
Inoue A; Iwahashi T; Koh CS; Yanagisawa N
Arerugi; 1994 Oct; 43(10):1270-6. PubMed ID: 7826223
[TBL] [Abstract][Full Text] [Related]
20. Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database.
Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Mazzeo A; Marfia GA; Cortese A; Fierro B; Jann S; Beghi E; Clerici AM; Carpo M; Schenone A; Luigetti M; Lauria G; Antonini G; Rosso T; Siciliano G; Cavaletti G; Liberatore G; Santoro L; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Toscano A; Mataluni G; Piccolo L; Cosentino G; Sabatelli M; Nobile-Orazio E;
J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):125-132. PubMed ID: 30297520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
